Treatment of chronic fatigue syndrome by dietary supplementation with omega-3 fatty acids--a good idea?
Minor alterations of immune, neuroendocrine, and autonomic function may be associated with the chronic fatigue syndrome. omega-3 fatty acids decrease the production of putative mediators of inflammation, including interleukin-1, and tumor necrosis factor. Since interleukin-1 and tumor necrosis factor are the principal polypeptide mediators of immunoregulation, reduced production of these cytokines by dietary supplementation with omega-3, may be a possible mechanism for the treatment of chronic fatigue syndrome.
Tamizi far
Babak
B
Department of Research, Isfahan University of Medical Sciences, Shahrekord, Isfahan, Iran. babak360@yahoo.com
Tamizi
B
B
D004035:Diet Therapy; D015673:Fatigue Syndrome, Chronic / Q000628:therapy*; D015525:Fatty Acids, Omega-3 / Q000627:therapeutic use*; D006801:Humans; D008962:Models, Theoretical
D015525:Fatty Acids, Omega-3